Background And Objectives: Croup is a clinical diagnosis, and the available evidence suggests that, except in rare cases, ancillary testing, such as radiologic imaging, is not helpful. Given the paucity of inpatient-specific evidence for croup care, we hypothesized that there would be marked variability in the use of not routinely indicated resources (NRIRs). Our primary study objective was to describe the variation and predictors of variation in the use of NRIRs.

Methods: This was a retrospective cohort study that used the Pediatric Health Information System database of generally healthy inpatients with croup aged 6 months to 15 years who were admitted between January 1, 2012 and September 30, 2014. We measured variability in the use of NRIRs: chest and lateral neck radiographs, viral testing, parenteral steroids, and antibiotics. Risk-adjusted analysis was used to compare resource utilization adjusted for hospital-specific effects and average case mix.

Results: The cohort included 26 hospitals and 6236 patients with a median age of 18 months. Nine percent of patients required intensive care services, and 3% had a 30-day readmission for croup. We found marked variability in adjusted and unadjusted utilization across hospitals for all resources. In the risk-adjusted analysis, hospital-specific effects rather than patient characteristics were the main predictor of variability in the use of NRIRs.

Conclusions: We observed an up to fivefold difference in NRIR utilization attributable to hospital-level practice variability in inpatient croup care. This study highlights a need for inpatient-specific evidence and quality-improvement interventions to reduce unnecessary utilization and to improve patient outcomes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369680PMC
http://dx.doi.org/10.1542/peds.2016-3582DOI Listing

Publication Analysis

Top Keywords

inpatient croup
8
inpatient-specific evidence
8
croup care
8
marked variability
8
risk-adjusted analysis
8
hospital-specific effects
8
croup
6
variability
5
variation inpatient
4
croup management
4

Similar Publications

Background: High-quality trial evidence supports the use of one dose of dexamethasone in the outpatient management of croup; however, there are no inpatient trials, and the optimal treatment regimen for the inpatient management of croup remains uncertain. Significant practice variability exists in the corticosteroid treatment of children hospitalized for croup.

Objective: To evaluate the association of dexamethasone treatment regimen (1 vs.

View Article and Find Full Text PDF
Article Synopsis
  • Croup and bronchiolitis are common reasons for kids to be hospitalized, but the impact of COVID-19 (SARS-CoV-2) on hospitalization rates is unclear.
  • This study analyzed health records from children with and without COVID-19 to see how their hospital experiences differed during the pandemic across different virus variant periods.
  • The findings revealed that while a small percentage of patients with croup and bronchiolitis tested positive for COVID-19, there were no significant differences in hospital utilization outcomes for those with and without the virus, suggesting minimal impact on healthcare resource use.
View Article and Find Full Text PDF

Consensus-based guideline for the supportive anthroposophic therapies to treat children with pseudocroup (stenosing laryngotracheitis).

Complement Ther Med

September 2024

Department of Pediatrics, Gemeinschaftskrankenhaus Herdecke, Germany; Faculty of Medicine, University of Duisburg-Essen, Germany.

Purpose: Supportive anthroposophic therapies are used to treat children with pseudocroup by pediatricians in outpatient and inpatient settings. Anthroposophic treatment comprises forms of creative therapies, external applications as well as remedies, which production is based on the knowledge of the human being, nature and substances. A scientifically based guideline for these therapies is lacking.

View Article and Find Full Text PDF

Potentially Avoidable Emergency Department Transfers for Acute Pediatric Respiratory Illness.

Acad Pediatr

August 2024

Division of Emergency Medicine (K Jafari, D Caglar, and E Hartford), Department of Pediatric, University of Washington, Seattle, Wash; Center for Clinical and Translation Research (K Jafari, A Gupta, D Caglar, and E Hartford), Seattle Children's Hospital, Seattle, Wash.

Background: Acute pediatric respiratory illness is one of the most common reasons for emergency department (ED) transfer; however, few studies have examined predictors of potentially avoidable ED transfer (PAT) in this subpopulation. This study aimed to characterize patterns and predictors of PATs in children with acute respiratory illness.

Methods: Cross-sectional analysis of 8,402,577 visits for patients ≤17 years from 2018 to 2019 Health Care Utilization Project State ED and Inpatient Datasets from New York, Maryland, Wisconsin, and Florida.

View Article and Find Full Text PDF

Croup, also known as laryngotracheobronchitis, frequently leads to blockages in the upper respiratory tract in young children, presenting symptoms, such as a raspy voice, a distinctive cough, and noisy breathing during inhalation. Despite being a condition that often resolves on its own, it puts considerable strain on healthcare resources due to regular doctor visits, emergency room usage, and occasional hospital stays. Research focused on larger populations suggests that only a small percentage of children with croup end up requiring hospital admission for their condition.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!